1. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway
    X Li et al, 2016, Oncogene CrossRef
  2. Apatinib Inhibits the Invasion and Metastasis of Liver Cancer Cells by Downregulating MMP-Related Proteins via Regulation of the NF-κB Signaling Pathway
    Xiaoxiao He et al, 2020, BioMed Research International CrossRef
  3. Lactotransferrin expression is downregulated and affects the mitogen-activated protein kinase pathway in gastric cancer
    GENGQIU LUO et al, 2015, Oncology Letters CrossRef
  4. Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
    Antje Richter et al, 2016, Cancers CrossRef
  5. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer
    Wan-Jiang Xue et al, 2016, Tumor Biology CrossRef
  6. Pancreatic Cancer Patient Survival Correlates with DNA Methylation of Pancreas Development Genes
    Michael J. Thompson et al, 2015, PLOS ONE CrossRef
  7. DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia
    Samareh Younesian et al, 2017, Leukemia Research CrossRef
  8. The Tumor Suppressor Role of the Ras Association Domain Family 10
    Yulong Hou et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  9. Predictive value of the serum RASSF10 promoter methylation status in gastric cancer
    Yilin Hu et al, 2019, Journal of International Medical Research CrossRef
  10. Epigenetic Control of Genes Involved in Cancer Initiation and Progression
    Sabita N. Saldanha et al, 2016, Epigenetic Advancements in Cancer CrossRef
  11. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer
    Junxun Ma et al, 2017, Medicine CrossRef
  12. Re‐expression ofLactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
    Jie Zhang et al, 2015, Journal of Oral Pathology & Medicine CrossRef
  13. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
    Fei Wang et al, 2016, Oncotarget CrossRef
  14. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer
    Fei Wang et al, 2017, Human Pathology CrossRef
  15. Ras-association domain family 10 acts as a novel tumor suppressor through modulating MMP2 in hepatocarcinoma
    W Liu et al, 2016, Oncogenesis CrossRef
  16. The coiled-coil domain of oncogene RASSF 7 inhibits hippo signaling and promotes non-small cell lung cancer
    Xiaoying Zheng et al, 2017, Oncotarget CrossRef
  17. Emerging strategies for sensitization of therapy resistant tumors toward cancer therapeutics by targeting the Bcl-2 family, TGF-β, Wnt/β-Catenin, RASSF and miRNA regulated signaling pathways
    Tarmarajen Veerasamy et al, 2021, The International Journal of Biochemistry & Cell Biology CrossRef